These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12696076)

  • 1. D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.
    Moresco RN; Vargas LC; Voegeli CF; Santos RC
    J Clin Lab Anal; 2003; 17(3):77-9. PubMed ID: 12696076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of latex agglutination kits for detection of fibrin(ogen) degradation products and D-dimer in healthy horses and horses with severe colic.
    Stokol T; Erb HN; De Wilde L; Tornquist SJ; Brooks M
    Vet Clin Pathol; 2005 Dec; 34(4):375-82. PubMed ID: 16270263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
    Song KS; Kim YA; Kim HK; Park Q
    Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma D-dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states.
    Wilde JT; Kitchen S; Kinsey S; Greaves M; Preston FE
    Br J Haematol; 1989 Jan; 71(1):65-70. PubMed ID: 2917130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads.
    Greenberg CS; Devine DV; McCrae KM
    Am J Clin Pathol; 1987 Jan; 87(1):94-100. PubMed ID: 3541576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of hypercoagulable states by measurement of activation fragments and peptides.
    Boisclair MD; Ireland H; Lane DA
    Blood Rev; 1990 Mar; 4(1):25-40. PubMed ID: 2182146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen degradation products in patients with the Quebec platelet disorder.
    Hayward CP; Welch B; Bouchard M; Zheng S; Rivard GE
    Br J Haematol; 1997 May; 97(2):497-503. PubMed ID: 9163623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between plasma levels of D-dimer and fibrinogen/fibrin degradation products (FDP) for exclusion of thromboembolic disorders.
    Moresco RN; Júnior RH; Cláudio Rosa Vargas L; Mariano da Rocha Silla L
    J Thromb Thrombolysis; 2006 Apr; 21(2):199-202. PubMed ID: 16622618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The D-dimer assay.
    Johnson ED; Schell JC; Rodgers GM
    Am J Hematol; 2019 Jul; 94(7):833-839. PubMed ID: 30945756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the levels of D-dimer by use of an alternative method based in the reaction time of fibrinogen/fibrin degradation products assay.
    Moresco RN; Vargas LC; Silla L
    J Thromb Thrombolysis; 2007 Aug; 24(1):73-6. PubMed ID: 17160549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widely Used Types and Clinical Applications of D-Dimer Assay.
    Riley RS; Gilbert AR; Dalton JB; Pai S; McPherson RA
    Lab Med; 2016 May; 47(2):90-102. PubMed ID: 27016528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of disseminated intravascular coagulation. Role of D-dimer.
    Carr JM; McKinney M; McDonagh J
    Am J Clin Pathol; 1989 Mar; 91(3):280-7. PubMed ID: 2646905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin D-dimer in thrombogenic disorders.
    Matsuo T; Kobayashi H; Kario K; Suzuki S
    Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
    Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
    Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical use of D-dimer testing].
    Lachâtre F; Gothot A
    Rev Med Liege; 2007 Jan; 62(1):29-35. PubMed ID: 17343127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-dimer concentrations in healthy dogs and dogs with disseminated intravascular coagulation.
    Stokol T; Brooks MB; Erb HN; Mauldin GE
    Am J Vet Res; 2000 Apr; 61(4):393-8. PubMed ID: 10772103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the automated and rapid STA Liatest D-dimer on the STA-R analyzer.
    Waser G; Kathriner S; Wuillemin WA
    Thromb Res; 2005; 116(2):165-70. PubMed ID: 15907532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis.
    Bozic M; Blinc A; Stegnar M
    Thromb Res; 2002 Nov; 108(2-3):107-14. PubMed ID: 12590945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.